Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002897975 | SCV003646260 | uncertain significance | Inborn genetic diseases | 2022-10-06 | criteria provided, single submitter | clinical testing | The c.3016G>T (p.V1006L) alteration is located in exon 19 (coding exon 17) of the SETD5 gene. This alteration results from a G to T substitution at nucleotide position 3016, causing the valine (V) at amino acid position 1006 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |